✦ LIBER ✦

T-lymphocyte subpopulations in the peripheral blood and bone marrow of patients with aplastic anemia

✍ Scribed by Falc�o, R. P. ;Voltarelli, J. C. ;Bottura, C.

Publisher: Springer-Verlag
Year: 1985
Weight: 291 KB
Volume: 50
Category: Article
ISSN: 1432-0584
DOI: 10.1007/bf00321173

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphocyte subpopulations in peripheral

Lymphocyte subpopulations in peripheral blood and bone marrow in patients with idiopathic myelofibrosis

✍ Vellenga, E. ;Poppema, S. ;Kallenberg, C. G. M. ;Halie, M. R. 📂 Article 📅 1987 🏛 Springer-Verlag ⚖ 322 KB

Detection of tumor necrosis factor-α in

Detection of tumor necrosis factor-α in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia

✍ Dr. John C. Schultz; Nasrollah T. Shahidi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

Supplemental peripheral blood stem cells

Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia

✍ Chang-Ki Min; Dong Wook Kim; Jong Wook Lee; Chi Wha Han; Woo Sung Min; Chun Choo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Analysis of bone marrow and peripheral b

Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome

✍ O. Iwase; S. Aizawa; Y. Kuriyama; M. Yaguchi; M. Nakano; K. Toyama 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 712 KB

Suppressor cell function and t lymphocyt

Suppressor cell function and t lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis

✍ Theresa L. Whiteside; Yasuo Kumagai; Alan D. Roumm; Robin Almendinger; Gerald P. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 616 KB

Ultrastructural evidence for persistent

Ultrastructural evidence for persistent gold in the bone marrow of a patient with aplastic anemia

✍ Bruce D. Cheson; Dr. Daniel O. Clegg; Farhad Moatamed 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Patients receiving gold therapy for rheumatoid arthritis or other inflammatory disorders may develop aplastic anemia, thrombocytopenia, agranulocytosis, proteinuria, glomerulopathy , dermatitis, and stomatitis (1-3). We describe a patient with chronic juvenile rheumatoid arthritis who developed apla